Emily Hewson

Dr Emily Hewson is a Cancer Institute NSW Early Career Fellow and member of the Sydney School of Health Sciences at the University of Sydney's Faculty of Medicine and Health. Her research focuses on advancing real-time radiation therapy techniques, particularly in managing intrafraction motion for prostate and other cancers. She leads projects involving multileaf collimator (MLC) tracking, dose optimization, and deep learning integration in radiation oncology.

Research interests include adaptive radiotherapy systems, kilovoltage intrafraction monitoring (KIM), and clinical trial implementation (e.g., TROG 15.01 SPARK trial). Her work emphasizes improving treatment accuracy through real-time dose-guided approaches and multitarget tracking for tumors with complex motion patterns.

• Developed experimental validations for MRI-linac integration and MLC tracking systems
• Authored a textbook chapter on Adaptive Radiation Therapy (ART)
• Recipient of Cancer Institute NSW Early Career Fellowship (2023)

Recent grants include an AI platform for targeted radiotherapy (2024) and national critical infrastructure funding for lung cancer applications (2023). Her lab collaborates on real-time dose calculation algorithms and clinical trial implementation across multiple institutions.